🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase III, Randomized, Observer-Blind, Controlled, Multicenter Clinical S...
Status
Completed
Location
MHAT St. Ekaterina
Start Date
2016-09-30
Trial ID
NCT02587221
This Phase 2, randomized, observer-blind, dose-confirmation clinical study ...
Status
Completed
Location
AMR Tempe
Start Date
2022-08-25
Trial ID
NCT05501561
Treatments Being Tested
Safety, Immunogenicity of an Adjuvanted Quadrivalent Subunit Influenza Viru...
Status
Completed
Location
Multiple Locations
Start Date
2014-10
Trial ID
NCT02255409
This is a multiple sites phase II trial, randomized, observer-blind, dose r...
Status
Completed
Location
MUHC-Vaccine Study Centre
Start Date
2014-07-16
Trial ID
NCT02236052
Safety, Immunogenicity and Efficacy of an Adjuvanted Quadrivalent Subunit I...
Status
Completed
Location
222, Novartis Investigational Site
Start Date
2013-11
Trial ID
NCT01964989
This Phase 2, randomized, observer-blind, active controlled clinical study ...
Status
Completed
Location
4022 - Coastal Clinical Research, an AMR company
Start Date
2020-10-08
Trial ID
NCT04576702
Treatments Being Tested
This randomized, partially-blinded, active comparator-controlled was conduc...
Status
Completed
Location
Optimal Sites
Start Date
2020-11-02
Trial ID
NCT04622592
Treatments Being Tested
The purpose of this study is to use an existing, unique clinical cohort: th...
Status
Completed
Location
Stanford LPCH Vaccine Program
Start Date
2017-09-19
Trial ID
NCT03312699
Treatments Being Tested
This Phase 3 study is a randomized, observer-blind study of MF59-adjuvanted...
Status
Completed
Location
84046-Accel Research Sites - Birmingham
Start Date
2023-10-23
Trial ID
NCT06087640
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerance, and immunog...
Status
Unknown
Location
Saint Louis University School of Medicine
Start Date
2015-07
Trial ID
NCT02500680
Treatments Being Tested